Literature DB >> 19954565

Symposium 1: Overnutrition: consequences and solutions. Obesity and cancer risk.

Timothy J Key1, Elizabeth A Spencer, Gillian K Reeves.   

Abstract

Epidemiological studies have provided convincing evidence that obesity increases the risk for cancers of the oesophagus (adenocarcinoma), colon, pancreas, breast (post-menopausal), endometrium and kidney. The magnitude of the increase in risk varies between cancer sites. For an increase in BMI of 10 kg/m2 relative risks are approximately 2.3 for adenocarcinoma of the oesophagus, 1.5 for colon cancer in men, 1.2 for colon cancer in women, 1.4 for post-menopausal breast cancer, 2.9 for endometrial cancer and >1.5 for kidney cancer, while the size of the effect on cancer of the pancreas is uncertain. There is also evidence that obesity increases the risks for cancers of the gallbladder, malignant melanoma, ovary, thyroid, non-Hodgkin lymphoma, multiple myeloma and leukaemia. Estimates of the percentage of cancers that can be attributed to excess body weight suggest that in the UK and similar countries approximately 5% of all cancers are attributable to overweight and obesity.

Entities:  

Mesh:

Year:  2009        PMID: 19954565     DOI: 10.1017/S0029665109991698

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  9 in total

1.  Early leptin intervention reverses perturbed energy balance regulating hypothalamic neuropeptides in the pre- and postnatal calorie-restricted female rat offspring.

Authors:  Leena Caroline Gibson; Bo-Chul Shin; Yun Dai; William Freije; Sudatip Kositamongkol; John Cho; Sherin U Devaskar
Journal:  J Neurosci Res       Date:  2015-01-29       Impact factor: 4.164

Review 2.  Poor awareness of risk factors for cancer in Irish adults: results of a large survey and review of the literature.

Authors:  Aoife M Ryan; Samantha Cushen; Harriët Schellekens; Eadaoin Ni Bhuachalla; Lisa Burns; Ursula Kenny; Derek G Power
Journal:  Oncologist       Date:  2015-03-06

3.  Longitudinal evaluation of cancer-associated biomarkers before and after weight loss in RENEW study participants: implications for cancer risk reduction.

Authors:  Faina Linkov; G Larry Maxwell; Ashley S Felix; Yan Lin; Diana Lenzner; Dana H Bovbjerg; Anna Lokshin; Meredith Hennon; John M Jakicic; Bret H Goodpaster; James P DeLany
Journal:  Gynecol Oncol       Date:  2011-12-22       Impact factor: 5.482

4.  The impact of body mass index on perioperative outcomes after robotic liver resection.

Authors:  Iswanto Sucandy; Abdelrahman Attili; Janelle Spence; Timothy Bordeau; Sharona Ross; Alexander Rosemurgy
Journal:  J Robot Surg       Date:  2019-02-01

5.  Role of BMI and hormone therapy in melanoma risk: a case-control study.

Authors:  Vincenzo De Giorgi; Alessia Gori; Imma Savarese; Antonietta D'Errico; Federica Scarfì; Federica Papi; Vincenza Maio; Piero Covarelli; Daniela Massi; Sara Gandini
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-13       Impact factor: 4.553

Review 6.  Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development.

Authors:  Min-Yu Chung; Tae Gyu Lim; Ki Won Lee
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

Review 7.  Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma.

Authors:  Marshall A Lichtman
Journal:  Oncologist       Date:  2010-10-07

Review 8.  The Roles of Vitamin A in the Regulation of Carbohydrate, Lipid, and Protein Metabolism.

Authors:  Wei Chen; Guoxun Chen
Journal:  J Clin Med       Date:  2014-05-07       Impact factor: 4.241

Review 9.  Current perspectives between metabolic syndrome and cancer.

Authors:  Carla Micucci; Debora Valli; Giulia Matacchione; Alfonso Catalano
Journal:  Oncotarget       Date:  2016-06-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.